Metabolomic analysis by nuclear magnetic resonance spectroscopy discriminates hormone receptor positive/HER2 negative breast cancer cell lines resistant to palbociclib
Abstract P6-02-07: Metabolomic analysis by nuclear magnetic resonance spectroscopy discriminates hormone receptor positive/HER2 negative breast cancer cell lines resistant to palbociclib / Bonechi, M; Guarducci, C; Meoni, G; Tenori, L; Biagioni, C; Schiff, R; Osborne, Ck; Luchinat, C; Di Leo, A; Malorni, L; Migliaccio, I. - In: CANCER RESEARCH. - ISSN 0008-5472. - STAMPA. - 77:(2017), pp. P6-02-07-P6-02-07. [10.1158/1538-7445.SABCS16-P6-02-07]
Abstract P6-02-07: Metabolomic analysis by nuclear magnetic resonance spectroscopy discriminates hormone receptor positive/HER2 negative breast cancer cell lines resistant to palbociclib
MEONI, GAIA;TENORI, LEONARDO;LUCHINAT, CLAUDIO;
2017
Abstract
Metabolomic analysis by nuclear magnetic resonance spectroscopy discriminates hormone receptor positive/HER2 negative breast cancer cell lines resistant to palbociclib
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
